Cardioprotective Effects of Flax Lignan Concentrate in Rats
Author Information
Author(s): Zanwar Anand A., Hegde Mahabaleshwar V., Bodhankar Subhash L.
Primary Institution: Poona College of Pharmacy, Bharati Vidyapeeth Deemed University
Hypothesis
The study aims to evaluate the cardioprotective activity of flax lignan concentrate (FLC) in isoprenalin-induced cardiotoxicity in rats.
Conclusion
Flax lignan concentrate significantly reduced isoprenalin-induced tachycardia and cardiotoxic effects in rats.
Supporting Evidence
- FLC treatment reversed biochemical changes caused by isoprenalin.
- Histopathological analysis showed reduced necrosis in FLC-treated rats.
- FLC significantly decreased levels of cardiac injury markers compared to the isoprenalin group.
Takeaway
This study found that flaxseed extract can help protect the heart from damage caused by a harmful substance called isoprenalin.
Methodology
Male Wistar rats were divided into three groups: control, isoprenalin-treated, and FLC-treated, with various biochemical and histopathological assessments conducted.
Limitations
The study was limited to a specific animal model and may not directly translate to human outcomes.
Participant Demographics
Male Wistar rats weighing 200–230 g.
Statistical Information
P-Value
p<0.01 for CK-MB, p<0.001 for LDH, p<0.05 for AST.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website